Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (Ⅲ) -acute graft-versus-host disease (2020)]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(7):529–36. https://doi.org/10.3760/cma.j.issn.0253-2727.2020.07.001.

Article  Google Scholar 

Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association. Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021. Zhonghua Xue Ye Xue Za Zhi. 2021;42(3):177–84. https://doi.org/10.3760/cma.j.issn.0253-2727.2021.03.001.

Article  Google Scholar 

Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013;369(6):529–39. https://doi.org/10.1056/NEJMoa1213299.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, et al. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood. 2011;118(25):6702–8. https://doi.org/10.1182/blood-2011-08-375006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choe H, Ferrara JLM. New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD). Expert Opin Ther Targets. 2021;25(9):761–71. https://doi.org/10.1080/14728222.2021.1992383.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schoettler ML, Bhatt H, Vasu S. A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy. Front Immunol. 2023;13:1064203. https://doi.org/10.3389/fimmu.2022.1064203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baccianti F, Masson C, Delecluse S, Li Z, Poirey R, Delecluse H-J, et al. Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response. mBio. 2023;14(5):e0178423. https://doi.org/10.1128/mbio.01784-23.

Article  CAS  PubMed  Google Scholar 

Domínguez-Martínez DA, Fontes-Lemus JI, García-Regalado A, Juárez-Flores Á, Fuentes-Pananá EM. IL-8 secreted by gastric epithelial cells infected with Helicobacter pylori CagA positive strains is a chemoattractant for epstein-barr virus infected B lymphocytes. Viruses. 2023;15(3):651. https://doi.org/10.3390/v15030651.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawitschka A, Lucchini G, Strahm B, Dalle JH, Balduzzi A, Gibson B, et al. Pediatric acute graft-versus-host disease prophylaxis and treatment: surveyed real-life approach reveals dissimilarities compared to published recommendations. Transpl Int. 2020;33(7):762–72. https://doi.org/10.1111/tri.13601.

Article  PubMed  Google Scholar 

Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT-NIH-CIBMTR task force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53(11):1401–15. https://doi.org/10.1038/s41409-018-0204-7.

Article  PubMed  PubMed Central  Google Scholar 

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29(3):191–204. https://doi.org/10.1016/j.blre.2014.11.001.

Article  PubMed  Google Scholar 

Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci. 2016;54(2):181–90. https://doi.org/10.1016/j.transci.2016.04.007.

Article  PubMed  PubMed Central  Google Scholar 

Zhang AP, Xiong H, Wang Z, Yang L, Qi SS, Nie YM, et al. The relationship between plasma sST2/Reg3α levels and acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29(4):1334–9. https://doi.org/10.19746/j.cnki.issn.1009-2137.2021.04.051.

Article  PubMed  Google Scholar 

Spyrou N, Levine JE, Ferrara JLM. Acute GVHD: new approaches to clinical trial monitoring. Best Pract Res Clin Haematol. 2022;35(4):101400. https://doi.org/10.1016/j.beha.2022.101400.

Article  PubMed  PubMed Central  Google Scholar 

Reshef R, Saber W, Bolaños-Meade J, Chen G, Chen YB, Ho VT, et al. Acute GVHD diagnosis and adjudication in a multicenter trial: a report from the BMT CTN 1202 biorepository study. J Clin Oncol. 2021;39(17):1878–87. https://doi.org/10.1200/JCO.20.00619.

Article  PubMed  PubMed Central  Google Scholar 

Etra A, El Jurdi N, Katsivelos N, Kwon D, Gergoudis S, Morales G, et al. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood Adv. 2024;8(12):3284–92. https://doi.org/10.1182/bloodadvances.2023011049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, et al. Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med. 2023;388(25):2338–48. https://doi.org/10.1056/NEJMoa2215943.

Article  PubMed  PubMed Central  Google Scholar 

Xiong YY, Liu L, Chen JB, Tang XQ, Xiao Q, Zhang HB, et al. Clinical study of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(2):513–21. https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.02.030.

Article  CAS  PubMed  Google Scholar 

Umezawa Y, Yoshifuji K, Tanaka K, Nogami A, Nagano K, Tsuji A, et al. Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2024;103(5):1737–44. https://doi.org/10.1007/s00277-024-05707-x.

Article  CAS  PubMed  Google Scholar 

Tajima T, Martinez OM, Bernstein D, Boyd SD, Gratzinger D, Lum G, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: a prospective multicenter study in the United States. Pediatr Transplant. 2024;28(4):e14763. https://doi.org/10.1111/petr.14763.

Article  PubMed  PubMed Central  Google Scholar 

Paczesny S. Post-haematopoietic cell transplantation outcomes: why ST2 became a “golden nugget” biomarker. Br J Haematol. 2021;192(6):951–67. https://doi.org/10.1111/bjh.16497.

Article  CAS  PubMed  Google Scholar 

Watkins B, Williams KM. Controversies and expectations for the prevention of GVHD: a biological and clinical perspective. Front Immunol. 2022;13:1057694. https://doi.org/10.3389/fimmu.2022.1057694.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasu S, Bostic M, Zhao Q, Sharma N, Puto M, Knight S, et al. Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults. Blood Adv. 2022;6(4):1342–9. https://doi.org/10.1182/bloodadvances.2021004933.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128(11):4970–9. https://doi.org/10.1172/JCI99261.

Article  PubMed  PubMed Central  Google Scholar 

Etra A, Gergoudis S, Morales G, Spyrou N, Shah J, et al. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv. 2022;6(12):3707–15. https://doi.org/10.1182/bloodadvances.2022007296.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, Ayuk FA, et al. A validated risk stratification that incorporates MAGIC biomarkers predicts long-term outcomes in pediatric patients with acute GVHD. Transplant Cell Ther. 2024;30(6):603.e1-603.e11. https://doi.org/10.1016/j.jtct.2024.03.022.

Article  CAS  PubMed  Google Scholar